Cote E (9 December 2014). "Albuterol Toxicosis". Clinical Veterinary Advisor - E-Book: Dogs and Cats. Elsevier Health Sciences. pp. 45–46. ISBN9780323240741. Archived from the original on 8 September 2017.
Bhushan R, Tanwar S (February 2010). "Different approaches of impregnation for resolution of enantiomers of atenolol, propranolol and salbutamol using Cu(II)-L-amino acid complexes for ligand exchange on commercial thin layer chromatographic plates". Journal of Chromatography A. 1217 (8): 1395–8. doi:10.1016/j.chroma.2009.12.071. PMID20074739.
Ip EJ, Doroudgar S, Lau B, Barnett MJ (August 2019). "Anabolic steroid users' misuse of non-traditional prescription drugs". Research in Social & Administrative Pharmacy. 15 (8): 949–952. doi:10.1016/j.sapharm.2018.07.003. PMID31303195. S2CID81614300.
Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, et al. (January 2011). "β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials". Sports Medicine. 41 (1): 39–57. doi:10.2165/11537540-000000000-00000. PMID21142283. S2CID189906919.
Schweizer C, Saugy M, Kamber M (September 2004). "Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete". Clinical Journal of Sport Medicine. 14 (5): 312–5. doi:10.1097/00042752-200409000-00018. PMID15377972. S2CID30402521.
Hostrup M, Jacobson GA, Jessen S, Lemminger AK (May 2020). "Anabolic and lipolytic actions of beta2 -agonists in humans and antidoping challenges". Drug Testing and Analysis. 12 (5): 597–609. doi:10.1002/dta.2728. PMID31960603. S2CID210842115.
drugs.com
"Salbutamol". Drugs.com. Archived from the original on 30 March 2016. Retrieved 11 April 2016.
World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Bhushan R, Tanwar S (February 2010). "Different approaches of impregnation for resolution of enantiomers of atenolol, propranolol and salbutamol using Cu(II)-L-amino acid complexes for ligand exchange on commercial thin layer chromatographic plates". Journal of Chromatography A. 1217 (8): 1395–8. doi:10.1016/j.chroma.2009.12.071. PMID20074739.
Ip EJ, Doroudgar S, Lau B, Barnett MJ (August 2019). "Anabolic steroid users' misuse of non-traditional prescription drugs". Research in Social & Administrative Pharmacy. 15 (8): 949–952. doi:10.1016/j.sapharm.2018.07.003. PMID31303195. S2CID81614300.
Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, et al. (January 2011). "β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials". Sports Medicine. 41 (1): 39–57. doi:10.2165/11537540-000000000-00000. PMID21142283. S2CID189906919.
Schweizer C, Saugy M, Kamber M (September 2004). "Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete". Clinical Journal of Sport Medicine. 14 (5): 312–5. doi:10.1097/00042752-200409000-00018. PMID15377972. S2CID30402521.
Hostrup M, Jacobson GA, Jessen S, Lemminger AK (May 2020). "Anabolic and lipolytic actions of beta2 -agonists in humans and antidoping challenges". Drug Testing and Analysis. 12 (5): 597–609. doi:10.1002/dta.2728. PMID31960603. S2CID210842115.
Ip EJ, Doroudgar S, Lau B, Barnett MJ (August 2019). "Anabolic steroid users' misuse of non-traditional prescription drugs". Research in Social & Administrative Pharmacy. 15 (8): 949–952. doi:10.1016/j.sapharm.2018.07.003. PMID31303195. S2CID81614300.
Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, et al. (January 2011). "β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials". Sports Medicine. 41 (1): 39–57. doi:10.2165/11537540-000000000-00000. PMID21142283. S2CID189906919.
Schweizer C, Saugy M, Kamber M (September 2004). "Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete". Clinical Journal of Sport Medicine. 14 (5): 312–5. doi:10.1097/00042752-200409000-00018. PMID15377972. S2CID30402521.
Hostrup M, Jacobson GA, Jessen S, Lemminger AK (May 2020). "Anabolic and lipolytic actions of beta2 -agonists in humans and antidoping challenges". Drug Testing and Analysis. 12 (5): 597–609. doi:10.1002/dta.2728. PMID31960603. S2CID210842115.
Cote E (9 December 2014). "Albuterol Toxicosis". Clinical Veterinary Advisor - E-Book: Dogs and Cats. Elsevier Health Sciences. pp. 45–46. ISBN9780323240741. Archived from the original on 8 September 2017.